“Hemostats Market” To Achieve An Estimation Of USD 4.5 Billion By 2024

The published report “Global Hemostats Market” has accounted to USD 2.7 billion in 2016, and is expected to reach USD 4.5 billion by 2024, growing at a CAGR of 6.6% in the forecast period 2017 to 2024.

Global Hemostats Market Report 2017 is a professional and in-depth study on the current status of the Hemostats industry. The report provides a basic overview of the industry including segmentation, drivers, applications and industry players.

• No of pages: 350

Report Segmentation

Global Hemostats Market, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Trends and Forecast to 2024

No of Figures: 50

Ask for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemostats-market

Global Hemostats Market – Segmentation:

The global hemostats market is segmented based on product type, indication, end-user and geography.

On the basis of product the market is segmented into into 5 product type’s thrombin based hemostats, combination agents hemostats, oxidized regeneration cellulose based hemostats, gelatin based hemostats and collagen based segments.

The Global Hemostats Market Report is also segmented based on indications type into wound closure and surgery.

Based on end-users the market is segmented into hospitals, clinics, ambulatory centers, community healthcare and others.

No of Tables: 250

Global Hemostats Market – Geographical Segmentation

Based on geography the global hemostats devices market covers data points for 52 countries across multiple geographies namely North & South America, Europe, Asia-Pacific and, Middle East & Africa. North America dominates the market in terms of consumption of hemostats followed by Europe and APAC.

Inquiry before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hemostats-market

The global hemostats market is highly concentrated market with major key players and local players to cater the domestic market. Ethicon US LLC dominated the hemostats market accounting for the highest market share in 2016, followed by Pfizer Inc., and C.R. Bard Inc. Other players in the market include Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, MedTrade Products Limited., Integra LifeSciences Corporation, Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring, Mallinckrodt, and Equimedical, B.V. holds a share of 15.3% of the global hemostats market in 2016.

ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC):

Founded in 1886 and headquartered at New Brunswick, New Jersey, U.S., Ethicon US, LLC., a subsidiary of Johnson & Johnson Services, Inc. is engaged in the development and marketing of healthcare products. The company operates through three business segments- Consumer, Pharmaceutical, and Medical Devices.

Recent developments:

1. In June, 2017 Ethicon US, LLC received FDA approval for SURGICEL powder absorbable hemostat. This hemostat powder will help surgeons to have a simple and predictable adjunctive hemostatic solution to control continuous oozing on broad or raw surfaces.

2. In August, 2016 Ethicon US, LLC collaborated with Touch Surgery to improve patient’s condition through Ethicon surgical products.

Pfizer:

Founded in 1849 and headquartered in New York, U.S., Pfizer Inc., is engaged in discovering, developing and, manufacturing of healthcare products. Pfizer operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment concentrates on creating and commercializing immunizations and prescriptions that enhance patients’ lives, and in addition products for the end user health care. The EH segment includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems, inadditon to research and development.

View Full Report Visit @ http://databridgemarketresearch.com/reports/global-hemostats-market/

Table of Content:

1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
5. HEMOSTATS MARKET, BY PRODUCT TYPE
6. HEMOSTATS MARKET, BY INDICATION
7. HEMOSTATS MARKET, BY END-USER
8. HEMOSTATS MARKET, BY GEOGRAPHY
8.1. COUNTRYWISE HEMOSTATS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
8.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
9. HEMOSTATS MARKET: COMPETITIVE LANDSCAPE
9.1. GLOBAL HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.2. U.S. HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.3. EUROPE HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.4. ASIA-PACIFIC HEMOSTATS MARKET: COMPANY SHARE ANALYSIS
9.5. MERGERS & ACQUISITIONS
9.6. NEW PRODUCT DEVELOPMENT & APPROVALS
9.7. EXPANSIONS
9.8. REGULATORY CHANGES
9.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
10. HEMOSTATS MARKET, COMPANY PROFILES
10.1. ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY)
10.2. PFIZER
10.3. C.R. BARD
10.4. BAXTER
10.5. VASCULAR SOLUTIONS, INC.
10.6. B.BRAUN MELSUNGEN
10.7. 3-D MATRIX, LTD
10.8. RESORBA MEDICAL GMBH (A ADVANCED MEDICAL SOLUTIONS GROUP PLC COMPANY)
10.9. ANIKA THERAPEUTICS, INC.
10.10. ARCH THERAPEUTICS INC.
10.11. BIOM’UP SAS
10.12. CRYOLIFE, INC.
10.13. GAMMA THERAPEUTICS, INC.
10.14. HEMOSTASIS, LLC
10.15. MEDTRADE PRODUCTS LTD.
10.16. INTEGRA LIFESCIENCES CORPORATION
10.17. MEDLINE INDUSTRIES, INC.
10.18. HEMOTEC MEDICAL GMBH
10.18.1. OVERVIEW
10.18.2. SWOT ANALYSIS
10.18.3. PRODUCT PORTFOLIO
10.18.4. REVENUE ANALYSIS
10.18.5. ANALYSTS VIEW
10.19. STRYKER
10.19.1. OVERVIEW
10.19.2. SWOT ANALYSIS
10.19.3. PRODUCT PORTFOLIO
10.19.4. REVENUE ANALYSIS
10.19.5. ANALYSTS VIEW
10.20. HEMOSTASIS, LLC.
10.20.1. OVERVIEW
10.20.2. SWOT ANALYSIS
10.20.3. PRODUCT PORTFOLIO
10.20.4. REVENUE ANALYSIS
10.20.5. ANALYSTS VIEW
10.21. CSL BEHRING
10.21.1. OVERVIEW
10.21.2. SWOT ANALYSIS
10.21.3. PRODUCT PORTFOLIO
10.21.4. REVENUE ANALYSIS
10.21.5. ANALYSTS VIEW
10.22. MALLINCKRODT PLC.
10.22.1. OVERVIEW
10.22.2. SWOT ANALYSIS
10.22.3. PRODUCT PORTFOLIO
10.22.4. REVENUE ANALYSIS
10.22.5. ANALYSTS VIEW
10.23. EQUIMEDICAL, B.V.
10.23.1. OVERVIEW
10.23.2. SWOT ANALYSIS
10.23.3. PRODUCT PORTFOLIO
10.23.4. REVENUE ANALYSIS
10.23.5. ANALYSTS VIEW

Related Report

Global Hernia Repair Devices Market – Industry Trends and Forecast to 2024

Global Hernia Repair Devices Market By Product Type, End User, Geography (North America, Europe, APAC, South America, MEA)–Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-hernia-repair-devices-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.